Aortic valve endocarditis in patients with bicuspid and tricuspid aortic valves.
AI, aortic insufficiency
AVR, aortic valve replacement
BAV, bicuspid aortic valve
HR, hazard ratio
IE, infective endocarditis
IQR, interquartile range
IV, intravenous
OR, odds ratio
TAV, tricuspid aortic valve
aortic valve
aortic valve replacement
bicuspid aortic valve
endocarditis
reoperation
survival
Journal
JTCVS open
ISSN: 2666-2736
Titre abrégé: JTCVS Open
Pays: Netherlands
ID NLM: 101768541
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
02
09
2021
accepted:
03
09
2021
entrez:
25
8
2022
pubmed:
26
8
2022
medline:
26
8
2022
Statut:
epublish
Résumé
To determine the long-term survival and rate of reoperation after surgical treatment of infective endocarditis (IE) in patients with a bicuspid aortic valve (BAV) and patients with a tricuspid aortic valve (TAV). Between 1997 and 2017, 210 patients underwent surgical treatment for native aortic valve endocarditis, including 51 patients with BAV (24%) and 159 patients with TAV (76%). Data were obtained from the Society of Thoracic Surgeons data warehouse and hospital medical record review, supplemented with surveys and national death index data for more complete follow-up. Compared with the TAV IE group, the BAV IE group was significantly younger (42 years vs 54 years) and had lower incidence rates of hypertension, coronary artery disease, and congestive heart failure (CHF). There were no significant between-group differences in postoperative stroke, sepsis, pacemaker requirement, or in-hospital mortality (2.0% vs 4.4%). Liver disease was a risk factor for operative mortality (odds ratio [OR], 13; 95% CI, 3.3-30; BAV patients develop IE requiring surgery at a younger age than TAV patients, but have significantly better long-term survival. Early detection of BAV is important to prevent IE and provide aggressive surgical treatment should IE occur.
Identifiants
pubmed: 36004079
doi: 10.1016/j.xjon.2021.09.007
pii: S2666-2736(21)00302-8
pmc: PMC9390515
doi:
Types de publication
Journal Article
Langues
eng
Pagination
228-236Subventions
Organisme : NHLBI NIH HHS
ID : K08 HL130614
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL141891
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL151776
Pays : United States
Informations de copyright
© 2021 The Author(s).
Références
Mayo Clin Proc. 2016 Jan;91(1):122-3
pubmed: 26763517
Int Heart J. 2017 Apr 6;58(2):220-224
pubmed: 28367850
Am J Cardiol. 1963 Dec;12:802-15
pubmed: 14088217
Am J Cardiol. 2004 Nov 15;94(10):1337-40
pubmed: 15541263
Heart. 2000 Jan;83(1):81-5
pubmed: 10618341
Circulation. 2012 Jul 3;126(1):11-2
pubmed: 22689928
J Am Dent Assoc. 2009 Oct;140(10):1238-44
pubmed: 19797553
J Thorac Cardiovasc Surg. 1999 Oct;118(4):588-94
pubmed: 10504620
J Am Coll Cardiol. 2015 May 19;65(19):2070-6
pubmed: 25975469
Tex Heart Inst J. 2009;36(2):111-6
pubmed: 19436803
Am J Cardiol. 2018 Dec 15;122(12):2104-2111
pubmed: 30343820
Crit Care. 2019 Apr 25;23(1):143
pubmed: 31027489
Ann Thorac Surg. 2007 Mar;83(3):931-7
pubmed: 17307436
Br Heart J. 1968 Sep;30(5):606-16
pubmed: 5676930
Am J Emerg Med. 2018 Sep;36(9):1686-1692
pubmed: 30001813
J Thorac Cardiovasc Surg. 2003 Sep;126(3):797-806
pubmed: 14502156
Enferm Infecc Microbiol Clin. 2017 Dec;35(10):645-650
pubmed: 27493083
Open Heart. 2017 May 16;4(1):e000545
pubmed: 28674620
Heart. 2010 Nov;96(21):1723-9
pubmed: 20478858
Br Heart J. 1968 Jul;30(4):514-26
pubmed: 5659398
J Thorac Cardiovasc Surg. 2021 Oct;162(4):1049-1059.e1
pubmed: 32418636
J Am Coll Cardiol. 1992 Feb;19(2):283-8
pubmed: 1732353
J Thorac Cardiovasc Surg. 2007 Apr;133(4):1028-36
pubmed: 17382648
Ann Thorac Surg. 2004 Jan;77(1):177-85
pubmed: 14726058
Infect Dis Clin North Am. 2009 Sep;23(3):643-64
pubmed: 19665088
Circulation. 2015 Oct 13;132(15):1435-86
pubmed: 26373316
Lancet. 2002 Apr 13;359(9314):1309-10
pubmed: 11965278
J Thorac Cardiovasc Surg. 2005 Aug;130(2):504-11
pubmed: 16077420
Clin Infect Dis. 2000 Feb;30(2):336-41
pubmed: 10671338